Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization

Journal of Biomedical Science

Volumn 13, Issue 5, 2006, Pages 695-702

  Yang, Pao Pao ^a   Huang, Eagle Yi Kung ^a   Yeh, Geng Chang ^b   Tao, Pao Luh ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Behavioral sensitization; Dextromethorphan; Dopamine; Methamphetamine; Nucleus accumbens; Rewarding; Ventral tegmental area

Indexed keywords

DEXTROMETHORPHAN; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; SENSITIZATION; WITHDRAWAL SYNDROME;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROMETHORPHAN; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; METHAMPHETAMINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; REWARD;

EID: 33749343488     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-006-9096-4     Document Type: Article

References (25)

1. Hoffman D.C., The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res. Bull. 23: 373-387, 1989.
2. Swerdlow N.R., Vaccarino F.J., Amalric M. and Koob G.F., The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol. Biochem. Behav. 25: 233-248, 1986.
3. Simon H., Scatton B. and Moal M.L., Dopaminergic A10 neurones are involved in cognitive functions. Nature 286: 150-151, 1980.
4. Kalivas P.W. and Stewart J., Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 16: 223-244, 1991.
5. Strakowski S.M. and Sax K.W., Progressive behavioral response to repeated D-amphetamine challenge: further evidence for sensitization in humans. Biol. Psych. 44: 1171-1177, 1998.
6. Wolf M.E., The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54: 679-720, 1998.
7. Tiseo P.J., Cheng J., Pasternak G.W. and Inturrisi C.E., Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J Pharmacol Exp Ther. 268: 195-201, 1994.
8. Trujillo K.A. and Akil H., Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend. 38: 139-154, 1995.
9. Tokuyama S., Wakabayashi H. and Ho I.K., Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. 295: 123-129, 1996.
10. Bem J.L. and Peck R., Dextromethorphan. An overview of safety issues. Drug Saf. 7: 190-199, 1992.
11. Church J., Sawyer D. and McLarnon J.G., Interactions of dextromethorphan with the N-methyl-D-aspartate receptor-channel complex: single channel recordings. Brain Res. 666: 189-194, 1994.
12. Farzin D., Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice. Eur. J. Pharmacol. 377: 35-42, 1999.
13. Mao J., Price D.D., Caruso F.S. and Mayer D.J., Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain 67: 361-368, 1996.
14. Huang E.Y., Liu T.C. and Tao P.L., Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn Schmiedebergs Arch. Pharmacol. 368: 386-392, 2003.
15. Ranaldi R., Munn E., Neklesa T. and Wise R.A., Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine). Psychopharmacology (Berl) 151: 192-201, 2000.
16. Tzschentke T.M., Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56: 613-672, 1998.
17. Joyce E.M. and Iversen S.D., The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci. Lett. 14: 207-212, 1979.
18. Vezina P. and Stewart J., Conditioning and place-specific sensitization of increases in activity induced by morphine in the VTA. Pharmacol. Biochem. Behav. 20: 925-934, 1984.
19. Kelly P.H., Seviour P.W. and Iversen S.D., Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94: 507-522, 1975.
20. Kim H.S. and Jang C.G., MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice. Brain Res. Bull. 44: 221-227, 1997.
21. Jhoo W.K., Shin E.J., Lee Y.H., Cheon M.A., Oh K.W., Kang S.Y., Lee C., Yi B.C. and Kim H.C., Dual effects of dextromethorphan on cocaine-induced conditioned place preference in mice. Neurosci. Lett. 288: 76-80, 2000.
22. Itzhak Y. and Martin J.L., Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology (Berl) 151: 226-233, 2000.
23. Ujike H., Tsuchida H., Kanzaki A., Akiyama K. and Otsuki S., Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization. Life Sci. 50: 1673-1681, 1992.
24. Li Y., Vartanian A.J., White F.J., Xue C.J. and Wolf M.E., Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology (Berl) 134: 266-276, 1997.
25. Segal D.S., Kuczenski R. and Florin S.M., Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration?. Behav. Neurosci. 109: 532-546, 1995.